TREM2 and β-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis

Journal of Immunology

Volumn 188, Issue 6, 2012, Pages 2612-2621

  Otero, Karel ^a   Shinohara, Masahiro ^b   Zhao, Haibo ^c,d   Cella, Marina ^a   Gilfillan, Susan ^a   Colucci, Angela ^a   Faccio, Roberta ^a   Patrick Ross, F ^e   Teitelbaum, Steve L ^a   Takayanagi, Hiroshi ^b   Colonna, Marco ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^e HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; MEMBRANE PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN TREM2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; ENZYME ACTIVATION; GENE DELETION; HETEROZYGOSITY; HOMEOSTASIS; IMMUNOFLUORESCENCE; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RNA ISOLATION; SIGNAL TRANSDUCTION;

EID: 84863239847     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102836     Document Type: Article

References (43)

1. Raggatt, L. J., and N. C. Partridge. 2010. Cellular and molecular mechanisms of bone remodeling. J. Biol. Chem. 285: 25103-25108.
2. Teitelbaum, S. L. 2007. Osteoclasts: what do they do and how do they do it? Am. J. Pathol. 170: 427-435. (Pubitemid 47339379)
3. Leibbrandt, A., and J. M. Penninger. 2009. RANKL/RANK as key factors for osteoclast development and bone loss in arthropathies. Adv. Exp. Med. Biol. 649: 100-113.
4. Barrow, A. D., N. Raynal, T. L. Andersen, D. A. Slatter, D. Bihan, N. Pugh, M. Cella, T. Kim, J. Rho, T. Negishi-Koga, et al. 2011. OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice. J. Clin. Invest. 121: 3505-3516.
5. Hamerman, J. A., M. Ni, J. R. Killebrew, C. L. Chu, and C. A. Lowell. 2009. The expanding roles of ITAM adapters FcRg and DAP12 in myeloid cells. Immunol. Rev. 232: 42-58.
6. Inui, M., Y. Kikuchi, N. Aoki, S. Endo, T. Maeda, A. Sugahara-Tobinai, S. Fujimura, A. Nakamura, A. Kumanogoh, M. Colonna, and T. Takai. 2009. Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12. Proc. Natl. Acad. Sci. USA 106: 4816-4821.
7. Ivashkiv, L. B. 2009. Cross-regulation of signaling by ITAM-associated receptors. Nat. Immunol. 10: 340-347.
8. Lanier, L. L. 2009. DAP10- and DAP12-associated receptors in innate immunity. Immunol. Rev. 227: 150-160.
9. Lee, S. H., T. S. Kim, Y. Choi, and J. Lorenzo. 2008. Osteoimmunology: cytokines and the skeletal system. BMB Rep. 41: 495-510.
10. Takayanagi, H. 2009. Osteoimmunology and the effects of the immune system on bone. Nat. Rev. Rheumatol. 5: 667-676.
11. Wu, Y., M. B. Humphrey, and M. C. Nakamura. 2008. Osteoclasts: the innate immune cells of the bone. Autoimmunity 41: 183-194. (Pubitemid 351454988)
12. McVicar, D. W., and G. Trinchieri. 2009. CSF-1R, DAP12 and b-catenin: a ménage à trois. Nat. Immunol. 10: 681-683.
13. McVicar, D. W., and D. N. Burshtyn. 2001. Intracellular signaling by the killer immunoglobulin-like receptors and Ly49. Sci. STKE 2001: re1.
14. Otero, K., I. R. Turnbull, P. L. Poliani, W. Vermi, E. Cerutti, T. Aoshi, I. Tassi, T. Takai, S. L. Stanley, M. Miller, et al. 2009. Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and β-catenin. Nat. Immunol. 10: 734-743.
15. Zou, W., J. L. Reeve, Y. Liu, S. L. Teitelbaum, and F. P. Ross. 2008. DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk. Mol. Cell 31: 422-431.
16. Kaifu, T., J. Nakahara, M. Inui, K. Mishima, T. Momiyama, M. Kaji, A. Sugahara, H. Koito, A. Ujike-Asai, A. Nakamura, et al. 2003. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J. Clin. Invest. 111: 323-332. (Pubitemid 36182208)
17. Koga, T., M. Inui, K. Inoue, S. Kim, A. Suematsu, E. Kobayashi, T. Iwata, H. Ohnishi, T. Matozaki, T. Kodama, et al. 2004. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428: 758-763. (Pubitemid 38508286)
18. Mócsai, A., M. B. Humphrey, J. A. Van Ziffle, Y. Hu, A. Burghardt, S. C. Spusta, S. Majumdar, L. L. Lanier, C. A. Lowell, and M. C. Nakamura. 2004. The immunomodulatory adapter proteins DAP12 and Fc receptor γ-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc. Natl. Acad. Sci. USA 101: 6158-6163. (Pubitemid 38520544)
19. Paloneva, J., M. Kestilä, J. Wu, A. Salminen, T. Böhling, V. Ruotsalainen, P. Hakola, A. B. Bakker, J. H. Phillips, P. Pekkarinen, et al. 2000. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat. Genet. 25: 357-361. (Pubitemid 30437329)
20. Paloneva, J., T. Manninen, G. Christman, K. Hovanes, J. Mandelin, R. Adolfsson, M. Bianchin, T. Bird, R. Miranda, A. Salmaggi, et al. 2002. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am. J. Hum. Genet. 71: 656- 662.
21. Paloneva, J., J. Mandelin, A. Kiialainen, T. Bohling, J. Prudlo, P. Hakola, M. Haltia, Y. T. Konttinen, and L. Peltonen. 2003. DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features. J. Exp. Med. 198: 669-675. (Pubitemid 37045349)
22. Humphrey, M. B., K. Ogasawara, W. Yao, S. C. Spusta, M. R. Daws, N. E. Lane, L. L. Lanier, and M. C. Nakamura. 2004. The signaling adapter protein DAP12 regulates multinucleation during osteoclast development. J. Bone Miner. Res. 19: 224-234. (Pubitemid 38116736)
23. Cella, M., C. Buonsanti, C. Strader, T. Kondo, A. Salmaggi, and M. Colonna. 2003. Impaired differentiation of osteoclasts in TREM-2-deficient individuals. J. Exp. Med. 198: 645-651. (Pubitemid 37040398)
24. Humphrey, M. B., M. R. Daws, S. C. Spusta, E. C. Niemi, J. A. Torchia, L. L. Lanier, W. E. Seaman, and M. C. Nakamura. 2006. TREM2, a DAP12- associated receptor, regulates osteoclast differentiation and function. J. Bone Miner. Res. 21: 237-245. (Pubitemid 43265289)
25. Shinohara, M., T. Koga, K. Okamoto, S. Sakaguchi, K. Arai, H. Yasuda, T. Takai, T. Kodama, T. Morio, R. S. Geha, et al. 2008. Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. Cell 132: 794-806. (Pubitemid 351312796)
26. Ito, Y., S. L. Teitelbaum, W. Zou, Y. Zheng, J. F. Johnson, J. Chappel, F. P. Ross, and H. Zhao. 2010. Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarization. J. Clin. Invest. 120: 1981-1993.
27. Mao, D., H. Epple, B. Uthgenannt, D. V. Novack, and R. Faccio. 2006. PLCγ2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2. J. Clin. Invest. 116: 2869-2879. (Pubitemid 44684472)
28. Nakano-Yokomizo, T., S. Tahara-Hanaoka, C. Nakahashi-Oda, T. Nabekura, N. K. Tchao, M. Kadosaki, N. Totsuka, N. Kurita, K. Nakamagoe, A. Tamaoka, et al. 2011. The immunoreceptor adapter protein DAP12 suppresses B lymphocyte-driven adaptive immune responses. J. Exp. Med. 208: 1661-1671.
29. Peng, Q., S. Malhotra, J. A. Torchia, W. G. Kerr, K. M. Coggeshall, and M. B. Humphrey. 2010. TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1. Sci. Signal. 3: ra38.
30. Mizoguchi, T., A. Muto, N. Udagawa, A. Arai, T. Yamashita, A. Hosoya, T. Ninomiya, H. Nakamura, Y. Yamamoto, S. Kinugawa, et al. 2009. Identification of cell cycle-arrested quiescent osteoclast precursors in vivo. J. Cell Biol. 184: 541-554.
31. Sankar, U., K. Patel, T. J. Rosol, and M. C. Ostrowski. 2004. RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1. J. Bone Miner. Res. 19: 1339-1348. (Pubitemid 41094376)
32. Park-Min, K. H., J. D. Ji, T. Antoniv, A. C. Reid, R. B. Silver, M. B. Humphrey, M. Nakamura, and L. B. Ivashkiv. 2009. IL-10 suppresses calcium-mediated costimulation of receptor activator NF-κB signaling during human osteoclast differentiation by inhibiting TREM-2 expression. J. Immunol. 183: 2444-2455.
33. Kalliolias, G. D., B. Zhao, A. Triantafyllopoulou, K. H. Park-Min, and L. B. Ivashkiv. 2010. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling. Arthritis Rheum. 62: 402-413.
34. Chang, J. H., E. J. Chang, H. H. Kim, and S. K. Kim. 2009. Enhanced inhibitory effects of a novel CpG motif on osteoclast differentiation via TREM-2 downregulation. Biochem. Biophys. Res. Commun. 389: 28-33.
35. Baron, R., and G. Rawadi. 2007. Targeting the Wnt/b-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 148: 2635-2643. (Pubitemid 46984775)
36. Takahashi, N., K. Maeda, A. Ishihara, S. Uehara, and Y. Kobayashi. 2011. Regulatory mechanism of osteoclastogenesis by RANKL and Wnt signals. Front. Biosci. 16: 21-30.
37. Hu, H., M. J. Hilton, X. Tu, K. Yu, D. M. Ornitz, and F. Long. 2005. Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 132: 49-60. (Pubitemid 40207966)
38. Glass, D. A., II, P. Bialek, J. D. Ahn, M. Starbuck, M. S. Patel, H. Clevers, M. M. Taketo, F. Long, A. P. McMahon, R. A. Lang, and G. Karsenty. 2005. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 8: 751-764. (Pubitemid 40585297)
39. Wei, W., D. Zeve, J. M. Suh, X. Wang, Y. Du, J. E. Zerwekh, P. C. Dechow, J. M. Graff, and Y. Wan. 2011. Biphasic and dosage-dependent regulation of osteoclastogenesis by β-catenin. Mol. Cell. Biol. 31: 4706-4719.
40. Kirstetter, P., K. Anderson, B. T. Porse, S. E. Jacobsen, and C. Nerlov. 2006. Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block. Nat. Immunol. 7: 1048- 1056.
41. Scheller, M., J. Huelsken, F. Rosenbauer, M. M. Taketo, W. Birchmeier, D. G. Tenen, and A. Leutz. 2006. Hematopoietic stem cell and multilineage defects generated by constitutive β-catenin activation. Nat. Immunol. 7: 1037- 1047.
42. Jiang, A., O. Bloom, S. Ono, W. Cui, J. Unternaehrer, S. Jiang, J. A. Whitney, J. Connolly, J. Banchereau, and I. Mellman. 2007. Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 27: 610-624. (Pubitemid 47615505)
43. Manicassamy, S., B. Reizis, R. Ravindran, H. Nakaya, R. M. Salazar-Gonzalez, Y. C. Wang, and B. Pulendran. 2010. Activation of β-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 329: 849-853.